SSY GROUP(02005): Obtained drug manufacturing registration for 5ml:100mg injection of dexmedetomidine hydrochloride.

12:04 03/03/2026

Shi Si Medicine Group (02005) announced that the group has obtained the drug production registration certificate for the injection of desmopressin hydrochloride (5ml:100mg) from the Chinese State Food and Drug Administration. It belongs to the third class of chemical drugs and is considered equivalent through consistency evaluation. The desmopressin hydrochloride injection of the group is the first domestic enterprise to be approved and is mainly used in the treatment of respiratory failure.

SSY GROUP (02005) announced that the group has obtained the drug production registration certificate for the hydrochloride of dexamethasone injection (5ml:100mg) from the China National Medical Products Administration. It belongs to the category 3 of chemical drugs and is considered to have passed the consistency evaluation. The hydrochloride of dexamethasone injection by the group is the first approved by a domestic enterprise and is mainly used for the treatment of respiratory failure.

MiniMax (00100) performance conference call: committed to transforming from an AI research and development company to a platform-based AI company.

HK Stock Market Move | Gold stocks fell further in the afternoon, and precious metals rose for two consecutive days before falling back. The soaring oil prices could drag down the performance of gold.

HK Stock Market Move | Most of the domestic banking stocks rose, with China Construction Bank Corporation (00939) and Industrial and Commercial Bank of China (01398) both up more than 2%.

MiniMax (00100) performance conference call: committed to transforming from an AI research and development company to a platform-based AI company.

HK Stock Market Move | Most of the domestic banking stocks rose, with China Construction Bank Corporation (00939) and Industrial and Commercial Bank of China (01398) both up more than 2%.